HTA Secrets Unlocked

An insightful webinar examining health technology assessment (HTA) agency behavior and key insights to consider when seeking reimbursement, including:

  • After regulatory approval, which HTA agency frequently issues decisions first?
  • Are orphan drugs recommended more often than non-orphan drugs?
  • For which agencies are orphan drug dossier requirements different than non-orphan drugs?
  • Do patient/professional submissions matter in gaining reimbursement?